INTRODUCTION

Methods
In this study we investigated for the first time, the association of 38 previously identified T2DM risk loci (32 loci from European and 6 loci from South Asian populations) in 1,166 T2DM patients and 1,235 healthy controls from Saudi Arabia.
Results
Common genetic variants (in or near WFS1, JAZF1, CDKN2A/B, TCF7L2, KCNQ1, HNF4A, and DUSP9) showed significant (P< 0.05) associations with T2DM in our study population. The effect sizes of these loci were comparable to those previously identified with the exception of HNF4A which showed a trend for larger effect size in our study population (OR, 95% CI; 1.27, 1.07-1.51) compared to that reported in South Asian populations (1.09, 1.06-1.12, I2 = 65.9). Analysis of risk allele scores (RAS) defined by the T2DM-associated loci showed that subjects in the top 20% of the RAS distribution (n = 480) had 2.5 fold increase in disease risk as compared to those in the bottom 20% (n = 480; P = 9.5 x 10-12). RAS were also associated with fasting glucose level (β = 0.12; P = 2.2 x 10-9) but not with BMI (P = 0.19). Cumulative contribution of the 8 significant loci to the risk of T2D. A) Risk allele scores defined by the eight loci associated with T2D risk is plotted against the odds ratio (OR) for T2D. Risk alleles were weighted according to their estimated effect size and weighted risk allele scores were divided into five equal parts (quintiles; Q). The OR for T2D risk was calculated for each quintile in reference to the third Quintile (Q3). B) Risk allele scores in realtion to fasing glucose level. C) Risk allele scores in realtion to BMI. *P<0.05; Vertical bars represent 95% confidence intervals.
Discussion
In the present study, the association of T2DM with 38 SNPs, that were previously identified and confirmed by genome wide association studies of European (32 SNPs) (1, (3) (4) (5) (6) (7) (8) (9) and South Asian (6 SNPs) (2) populations, was investigated in the Saudi population (RIYADH cohort). Among the 37SNPs passing quality control measures, 8 SNPs showed significant association with T2DM at the nominal level (P<0.05) and two other SNPs showed borderline significant associations. The direction of effect of the T2DM-associated SNPs in our study population was consistent with previously reported results in other populations however, there was generally a trend for larger effect size in our population but this was not statistically significant. The SNP at TCF7L2 showed the strongest association signal and the largest effect size in our study population which is consistent with results reported in other populations (4,5,7,8).
In conclusion we have shown for the first time that variants at WFS1, JAZF1, CDKN2A/B, TCF7L2, KCNQ1, HNF4A, and DUSP9 are associated with T2DM in the Saudi population but further larger studies will be required to confirm these findings in other Middle Eastern populations with high T2DM prevalence and to identify other T2DM-susceptibility loci.. Table 1 . Relevant characteristic of the study population Figure S1 . ROC curve analysis of loci associated with T2D in the Saudi population. 
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